tiprankstipranks
Argenica Therapeutics Ltd (AU:AGN)
ASX:AGN
Australian Market

Argenica Therapeutics Ltd (AGN) Ownership - Who Owns Argenica Therapeutics Ltd?

3 Followers

Argenica Therapeutics Ltd (AGN) Ownership Overview

4.05%0.00%0.00%95.95%
4.05%
Insiders
0.00% Other Institutional Investors
95.95% Public Companies and
Individual Investors
The ownership structure of Argenica Therapeutics Ltd (AU:AGN) stock is a mix of institutional, retail and individual investors. Approximately 0.00% of the company’s stock is owned by Institutional Investors, 4.05% is owned by Insiders and 95.95% is owned by Public Companies and Individual Investors.
The ownership structure of Argenica Therapeutics Ltd (AU:AGN) stock is a mix of institutional, retail and individual investors. Approximately 0.00% of the company’s stock is owned by Institutional Investors, 4.05% is owned by Insiders and 95.95% is owned by Public Companies and Individual Investors.

Top Shareholders

Holder
# of Shares
Type
% Holding
Value
4,436,690Insider3.61%2,417,996
487,520Insider0.40%265,698
50,000Insider0.04%27,250

Top Mutual Fund Holders

Currently, No Data Available
Holder
# of Shares
Type
% Holding
Value

Top ETF Holders

Currently, No Data Available
Holder
# of Shares
Type
% Holding
Value

FAQ

Who Owns Argenica Therapeutics Ltd (AU:AGN)?
According to the latest TipRanks data, approximately 0.00% of the company's stock is held by institutional investors, 4.05% is held by insiders, and 95.95% is held by retail investors.
    What percentage of Argenica Therapeutics Ltd (AU:AGN) stock is held by institutional investors?
    According to the latest TipRanks data, approximately 0.00% of Argenica Therapeutics Ltd (AU:AGN) stock is held by institutional investors.
      What percentage of Argenica Therapeutics Ltd (AU:AGN) stock is held by retail investors?
      According to the latest TipRanks data, approximately 95.95% of Argenica Therapeutics Ltd (AU:AGN) stock is held by retail investors.
        Who owns the most shares of Argenica Therapeutics Ltd (AU:AGN)?
        Geoff Pocock owns the most shares of Argenica Therapeutics Ltd (AU:AGN).
          What is the significance of the ownership structure for a publicly traded company?
          The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
            What's Included in PREMIUM?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis